Cite
984 FAULTY RISK PREDICTION OF PROSTATE CANCER BY NOMOGRAMS WITHOUT CONSIDERING PSA INTER-ASSAY VARIABILITY
MLA
Stephan, C., et al. “984 Faulty Risk Prediction of Prostate Cancer by Nomograms without Considering Psa Inter-Assay Variability.” European Urology Supplements, vol. 9, no. 2, Apr. 2010, pp. 308–09. EBSCOhost, https://doi.org/10.1016/S1569-9056(10)60963-3.
APA
Stephan, C., Siemßen, K., Friedersdorff, F., Cammann, H., Deger, S., Schrader, M., Lein, M., Jung, K., Meyer, H. A., & Miller, K. (2010). 984 Faulty Risk Prediction of Prostate Cancer by Nomograms without Considering Psa Inter-Assay Variability. European Urology Supplements, 9(2), 308–309. https://doi.org/10.1016/S1569-9056(10)60963-3
Chicago
Stephan, C., K. Siemßen, F. Friedersdorff, H. Cammann, S. Deger, M. Schrader, M. Lein, K. Jung, H.A. Meyer, and K. Miller. 2010. “984 Faulty Risk Prediction of Prostate Cancer by Nomograms without Considering Psa Inter-Assay Variability.” European Urology Supplements 9 (2): 308–9. doi:10.1016/S1569-9056(10)60963-3.